Xtant medical holdings, inc. (XTNT)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Operating activities:
Net Loss

-8,221

-70,099

-52,411

-19,493

-2,174

-10,507

-12,693

-7,713

-3,006

-19,467

Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization

3,143

6,590

8,409

7,241

4,889

952

753

782

755

682

(Gain) loss on disposal of fixed assets

61

-103

-21,242

0

-

-

-

-

-

-

Impairment of goodwill and intangible assets

-

48,146

-

-

-

-

-

-

-

-

Purchase accounting valuation allowance

-

-

-

-

17,537

0

-

-

-

-

Non-cash consideration associated with stock purchase agreement

-

-

-

-

558

0

-

-

-

-

Impairment of Assets

-

-

-

-

956

912

-

-

-

-

Warrants issued for services

-

-

-

-

-

-

-

342

0

-

Non-cash interest

5,726

9,848

14,685

6,784

4,814

814

633

196

-

-

Non-cash rent

20

-

-

-

-

-

-

-

-

-

Stock-based compensation

515

694

212

522

836

935

838

1,554

2,555

2,849

Amortization of debt discount

-

-

-

-

-

1,632

1,251

502

302

-

Impairment of Assets

-

-

-

-

-

-

728

-

-

-

Non-Cash Interest

-

-

-

-

-

-

-

-

-

870

Loss on sale of fixed assets

-

-

-10

-25

596

-25

0

-

-

-

Write-off of debt discount

-

-

-

-

-

-

-

705

1,307

-

Write-off of debt discount

-

-

-

-

-

-

-

-

1,307

-

Provision for reserve on accounts receivable

513

188

-

-

-

-

-

-

795

-

Provision for excess and obsolete inventory

509

4,932

-

-

-

-

-

-

-

-

Provision for losses on accounts receivable and inventory

-

-

4,213

223

700

647

2,320

636

1,425

-

Provision for losses on accounts receivable and inventory

-

-

-

-

-

-

-

-

-

814

Change in derivative warrant liability

-

-

-

-

-

-

-

-

-

9,206

Loss on impairment of intangible assets

-

-

-

-

-

-

-

-

-

183

Change in warrant derivative liability

3

121

203

-

-

-

-

-

-

-

Loss on disposal of assets

-

-

-

-

-

-

-

-7

0

-

Non-cash interest

-

-

-

-

-

-

-

-

0

-

Provision for losses on accounts receivable and inventory

-

-

4,213

223

-

-

-

-

1,425

-

Change in derivative warrant liability

-

-

-

716

270

1,736

875

1,360

6,377

-

Extinguishment of debt

-

-

-

-

2,345

0

-

-

-

-

Decrease of contingent liability

-

-

-

-

-

-

-91

-

-

-

Reduction of contingent liability

-

-

-

-

-

-

-

358

0

-

Changes in operating assets and liabilities:
Accounts receivable

647

-2,536

-4,747

2,680

5,512

-283

-797

414

4,636

2,283

Accounts receivable - related party

-

-

-

-

-

-

-

-

181

-

Accounts receivable - related party

-

-

-

-

-

-

-

-

-

342

Inventories

-692

-40

-2,122

4,074

545

17

-747

5,271

2,365

2,618

Prepaid and other assets

-204

-1,055

460

484

1,044

455

-263

1,049

190

624

Accounts payable

-4,278

-3,011

-1,637

319

644

715

-1,001

1,249

334

1,429

Accrued liabilities

1,475

311

-1,472

-2,076

7,527

-1,526

1,434

-602

1,920

927

Net cash used in operating activities

-

-

-

-

-9,099

-

-

-10,792

-

-

Net cash (used in) provided by operating activities

-413

1,212

-543

-14,407

-

-7,324

-4,892

-

-7,362

-8,371

Investing activities:
Impairment of goodwill

-

-

-

-

-

-

-

0

-

-

Purchases of property and equipment and intangible assets

879

624

-

-

-

-

-

-

962

783

Notes receivable from stockholder

-

-

-

-

-

-

-

-

82

-

Acquisition of X-spine Systems, Inc.

-

-

-

-

72,975

0

-

11

137

33

Purchases of property and equipment and intangible assets

-

-

1,641

5,832

2,263

299

623

1,825

-

-

Proceeds from sale of fixed assets

335

257

33

16

1,667

1

-70

-

-

-

Net cash used in investing activities

-544

-367

-1,608

-5,816

-

-298

-693

-

-1,017

-816

Financing activities:
Payments on capital leases

455

359

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-73,571

-

-

-1,836

-

-

Proceeds from long-term and convertible debt, net of deferred and financing costs

-

-

12,787

-

-

-

0

22,741

9,579

3,973

Payment of royalty obligation

-

-

-

-

542

-

-

-

-

-

Payments on convertible debt

-

-

-

-

-

-

-

-

-

1,790

Payments on notes payable

-

-

-

-

-

-

-

-

-

1,074

Proceeds from long-term and convertible debt, net of deferred and financing costs

-

-

-

3,238

-

-

-

-

-

-

Payments on financing leases

-

-

88

144

101

171

149

78

36

68

Costs associated with Second Amended and Restated Credit Agreement

-148

-

-10,448

10,252

-

-

-

-

-

-

Costs associated with conversion of debt and private placement

-

3,356

-

-

-

-

-

-

-

-

Payments on long-term debt

-

-

-

-

1,325

653

621

9,784

5,115

1,588

Proceeds from equity private placement

-

6,810

-

-

515

0

-

-

-

-

Proceeds from the issuance of Convertible Debt

-

-

-

-

83,897

4,000

-

-

-

4,700

Proceeds from Revolving Line of Credit

-

-

-

-

0

-

-

-

-

-

Proceeds from exercise of options

-

-

-

-

11

0

27

46

1,010

40

Net proceeds from issuance of stock and warrants

-

1

178

3,087

2,116

-

-

-

-

-

Payments on related party notes

-

-

-

-

-

-

-

-

-

183

Proceeds from issuance of stock

-

-

-

-

-

5,869

4,450

3,879

2,974

5,160

Net cash provided by financing activities

-

-

-

-

84,570

-

-

16,804

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

389

1,018

Purchase of treasury stock

-

-

-

-

-

-

-

-

-

726

Net cash used in financing activities

-603

3,096

2,429

16,433

-

9,044

3,705

-

8,803

9,461

Net change in cash and cash equivalents

-1,560

3,941

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

278

-3,789

1,899

1,421

-1,879

4,174

423

273